Related Resources

Drug treatment for antisocial personality disorder (ASPD) is one of the most debated topics in psychiatry — and for good reason. Here’s what you need to know right away:
Quick Answer: Key Facts About ASPD Drug Treatment
| Question | Answer |
|---|---|
| Are there FDA-approved medications for ASPD? | No — none exist specifically for ASPD |
| What do medications target? | Symptoms like aggression, impulsivity, and co-occurring depression or anxiety |
| Which drugs are most commonly used? | SSRIs, mood stabilizers (lithium, valproate), low-dose antipsychotics |
| Is medication enough on its own? | No — therapy is always recommended alongside medication |
| Does the evidence support drug treatment? | Limited; a Cochrane review found only low-certainty evidence across 11 trials |
ASPD is a serious mental health condition marked by persistent patterns of deception, impulsivity, aggression, and a striking lack of remorse for harming others. It affects an estimated 1% to 4% of U.S. adults and is far more common in men than women.
What makes ASPD uniquely difficult to treat is that most people with the disorder don’t believe they need help. They often seek care indirectly — through struggles with depression, anxiety, or substance use — rather than recognizing the personality disorder itself.
This creates a real challenge for clinicians, families, and patients alike: how do you treat something pharmacologically when no approved medication exists, the evidence is thin, and the person may not want treatment in the first place?
At Psyclarity Health, we specialize in evidence-based residential mental health care for individuals dealing with complex conditions like ASPD, co-occurring substance use disorders, and treatment-resistant mood disorders — including navigating the limited but important role that drug treatment for antisocial personality disorder can play in a broader care plan. Our multidisciplinary team is experienced in building individualized treatment strategies that go beyond medication alone.

When we talk about drug treatment for antisocial personality disorder, we have to start with a dose of reality: there are currently no medications specifically approved by the Food and Drug Administration (FDA) to treat ASPD. Because the disorder is defined by a long-standing pattern of behavior and personality traits rather than a single chemical imbalance, “curing” it with a pill isn’t an option.
However, that doesn’t mean psychiatrists are empty-handed. Doctors often use medications “off-label.” This means they prescribe drugs approved for other conditions—like depression or epilepsy—to help manage the most disruptive symptoms of ASPD. According to the Mayo Clinic, the goal of medication in this context is usually to stabilize the patient so they can actually engage in talk therapy.
We often see three main “target symptoms” when considering pharmacological interventions:
Research into the biology of ASPD suggests that some individuals may have deficits in their serotonergic system (the part of the brain that regulates mood and impulse control). By using medications that influence serotonin or other neurotransmitters, we aim to bridge the gap between a reactive brain and a thoughtful one. To learn more about how these patterns form, you can explore our guide on understanding the complexities of personality disorders.
If you’re looking for a “magic bullet” for ASPD, the medicine cabinet can feel a bit sparse. However, several classes of drugs are commonly utilized to take the edge off the disorder’s most damaging features.
| Medication Class | Common Examples | Primary Target Symptom |
|---|---|---|
| SSRIs (Antidepressants) | Fluoxetine, Sertraline | Irritability, depression, anxiety |
| Mood Stabilizers | Lithium, Carbamazepine, Valproate | Impulsivity, mood swings, aggression |
| Antipsychotics | Risperidone, Quetiapine | Severe aggression, violent behavior |
| Antiepileptics | Phenytoin | Impulsive (but not premeditated) aggression |
The Cochrane review on this topic is the “gold standard” of medical evidence, and its findings are sobering. After reviewing 11 randomized controlled trials (RCTs) involving 416 participants, researchers concluded that the evidence is “insufficient to draw conclusions” about the widespread effectiveness of these drugs. Most studies were small, short-term, and primarily involved men in prison or substance abuse clinics.
While the overall evidence is thin, some specific drugs have shown a glimmer of hope in clinical trials. For instance, phenytoin (an anti-seizure medication) was found in one study of male prisoners to reduce the frequency and intensity of impulsive aggressive acts. It didn’t stop them from planning crimes (premeditated aggression), but it did seem to help them keep their cool in the heat of the moment.
Other drugs mentioned in the NCBI research include:
The major takeaway from the research is that while these drugs might help a specific symptom, they don’t change the underlying personality structure. Furthermore, because many of these studies are older or have methodological flaws, clinicians must weigh the potential benefits against the risks very carefully.
Prescribing medication for ASPD isn’t without its downsides. Because these drugs are often powerful, they come with a laundry list of potential side effects that can make “patient compliance” (actually taking the pills) a major hurdle.
Common issues include:
At Psyclarity Health, we emphasize that medication management must be a collaborative, highly monitored process. We don’t just hand out a prescription; we watch for these side effects and adjust dosages to ensure the treatment isn’t worse than the symptoms.
It is rare to find ASPD existing all by itself. In fact, it’s much more common for it to bring “uninvited guests” like drug or alcohol addiction. This is what we call a dual diagnosis.
The link between ASPD and substance use is incredibly strong. Statistics show that the prevalence of ASPD is between 7% and 40% among men with existing substance use disorders (SUDs). In prison populations, these numbers skyrocket, with some estimates suggesting up to 63% of male remand prisoners meet the criteria for ASPD.
Why the connection? Often, it comes down to shared risk factors. Childhood trauma, genetic predispositions, and a “flat” stress response can lead an individual to seek out the “high” of drugs or the numbing effect of alcohol. You can read more about the lack of effective approaches to addiction treatment for these individuals and why specialized care is so vital.
Because ASPD and addiction are so intertwined, treating one without the other is like trying to fix a leaky boat by only painting the hull. Integrated treatment—addressing both the personality disorder and the chemical dependency at the same time—is the only way to see real progress.
We focus on:
For a deeper dive into how these conditions overlap, see our article on the importance of integrated treatment for dual diagnosis and the connection between BPD and addiction, as many Cluster B disorders share similar treatment hurdles.
If medication is the “stabilizer,” then psychotherapy is the “engine” of change. Since there is no “cure” in a bottle, the heavy lifting of ASPD treatment happens in the therapist’s office.
The NICE guidelines emphasize that psychological treatments are the first line of defense. These aren’t your standard “how does that make you feel?” sessions. They are structured, goal-oriented, and often challenging.
One encouraging fact is that ASPD often improves with age. Symptoms like blatant criminality and physical aggression tend to peak in the 20s and 30s and may naturally subside after age 40. However, waiting for “nature to take its course” isn’t a strategy. Active charting of a new course through intensive therapy can protect the individual and their family from years of chaos.
No. There are currently no medications specifically approved by the FDA for the treatment of antisocial personality disorder. All pharmacological treatments are used off-label to manage specific symptoms like aggression or co-occurring disorders like depression.
Medication cannot “cure” ASPD because it is a personality disorder involving deep-seated traits and behaviors rather than a temporary illness. However, medication can be an effective tool for managing symptoms that interfere with a person’s ability to function or participate in therapy.
Clinicians often use mood stabilizers (like lithium or valproate), low-dose antipsychotics (like risperidone), or certain antiepileptics (like phenytoin) to help reduce impulsive aggression and violent outbursts.
Navigating drug treatment for antisocial personality disorder is a complex journey that requires patience, expert guidance, and a realistic outlook. While medication isn’t a “fix-all,” it can be a vital bridge to stability when used as part of a comprehensive, integrated care plan.
At Psyclarity Health, we believe in a holistic approach to mental health. Our residential programs in Los Angeles and San Diego offer a safe, structured environment where individuals can receive treatment from masters-level therapists. We combine traditional evidence-based therapies with holistic options like yoga, art therapy, and psychodrama to treat the whole person, not just a diagnosis.
If you or a loved one are struggling with the challenges of ASPD and co-occurring addiction, progress is possible with the right support. We offer same-day admissions and strict confidentiality to help you start charting a new course today. Reach out to us to learn more about our individualized treatment programs.